While the body does produce natural GLP-1, this endogenous hormone is rapidly broken down by the enzyme dipeptidyl peptidase-4 (DPP-4) within minutes of secretion, making it unsuitable as a therapeutic agent without pharmaceutical modification
People who experienced stomach paralysis after taking Ozempic should work with their doctor to obtain the proper gastric testing to prove their injuries
Risk-stratified prescribing should therefore align agent selection, dose escalation, and monitoring intensity with patient-specific vulnerabilities, particularly gastrointestinal tolerability, risk of renal dehydration, gallbladder history, retinopathy risk during rapid glycaemic improvement, and frailty or sarcopenia risk
The combined effect of GLP-1 on appetite regulation and digestion makes it an invaluable ally in the battle against excess weight
Positive Effects of Soy Lecithin-Derived Phosphatidylserine plus Phosphatidic Acid on Memory, Cognition, Daily Functioning, and Mood in Elderly Patients with Alzheimers Disease and Dementia
Mitochondrial dysfunction and oxidative stress in heart disease